ARYx Therapeutics

^{, Nasdaq: ARYX}

Re-engineering commercially successful drugs to eliminate safety issues.

Industry: Health Care

First Day Return: -19.0%

ARYX

Re-engineering commercially successful drugs to eliminate safety issues.

IPO News for ARYx Therapeutics

Cumberland Pharmaceuticals prices IPO at $17, below the range 08/10/09
ALERT: Worst weekly perfomers: ARYx Therapeutics, Encore Bancshares, American Public Education 05/30/09
ALERT: Worst weekly perfomers: ARYx Therapeutics, Whiting USA Trust I, MSCI 05/23/09

IPO Data
IPO Date	11/06/2007
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$50
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.aryx.com
Headquarters	Fremont, CA, United States
Founded	2004
Employees at IPO	70

IPO News for ARYx Therapeutics

ARYx Therapeutics (ARYX) Performance